194 related articles for article (PubMed ID: 36948020)
1. Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA).
Zhang Z; Hong W; Wu Q; Tsavachidis S; Li JR; Amos CI; Cheng C; Sartain SE; Afshar-Kharghan V; Dong JF; Bhatraju P; Martin PJ; Makar RS; Bendapudi PK; Li A
Thromb Res; 2023 May; 225():39-46. PubMed ID: 36948020
[TBL] [Abstract][Full Text] [Related]
2. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.
Okamura H; Nakamae H; Shindo T; Ohtani K; Hidaka Y; Ohtsuka Y; Makuuchi Y; Kuno M; Takakuwa T; Harada N; Nishimoto M; Nakashima Y; Koh H; Hirose A; Nakamae M; Wakamiya N; Hino M; Inoue N
Front Immunol; 2021; 12():695037. PubMed ID: 34326846
[TBL] [Abstract][Full Text] [Related]
3. Late transplant-associated thrombotic microangiopathy verified in bone marrow biopsy specimens is associated with chronic GVHD and viral infections.
Hill W; Sotlar K; Hautmann A; Kolb HJ; Ullmann J; Hausmann A; Schmidt M; Tischer J; Pham TT; Rank A; Hoechstetter MA
Eur J Haematol; 2024 May; 112(5):819-831. PubMed ID: 38243840
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy.
Gavriilaki E; Touloumenidou T; Sakellari I; Batsis I; Mallouri D; Psomopoulos F; Tsagiopoulou M; Koutra M; Yannaki E; Papalexandri A; Taylor P; Nikolousis E; Stamouli M; Holbro A; Baltadakis I; Liga M; Spyridonidis A; Tsirigotis P; Charchalakis N; Tsakiris DA; Brodsky RA; Passweg J; Stamatopoulos K; Anagnostopoulos A
Thromb Haemost; 2020 Apr; 120(4):638-646. PubMed ID: 32131130
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.
Qi J; Wang J; Chen J; Su J; Tang Y; Wu X; Ma X; Chen F; Ruan C; Zheng XL; Wu D; Han Y
Ann Hematol; 2017 Nov; 96(11):1849-1855. PubMed ID: 28801815
[TBL] [Abstract][Full Text] [Related]
6. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
Sartain S; Shubert S; Wu MF; Wang T; Martinez C
Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
[TBL] [Abstract][Full Text] [Related]
7. Interferon-complement loop in transplant-associated thrombotic microangiopathy.
Jodele S; Medvedovic M; Luebbering N; Chen J; Dandoy CE; Laskin BL; Davies SM
Blood Adv; 2020 Mar; 4(6):1166-1177. PubMed ID: 32208488
[TBL] [Abstract][Full Text] [Related]
8. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
9. The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.
Jodele S; Zhang K; Zou F; Laskin B; Dandoy CE; Myers KC; Lane A; Meller J; Medvedovic M; Chen J; Davies SM
Blood; 2016 Feb; 127(8):989-96. PubMed ID: 26603840
[TBL] [Abstract][Full Text] [Related]
10. Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients.
Jodele S; Sabulski A
Expert Rev Hematol; 2021 Aug; 14(8):751-763. PubMed ID: 34301169
[TBL] [Abstract][Full Text] [Related]
11. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
Jodele S; Dandoy CE; Sabulski A; Koo J; Lane A; Myers KC; Wallace G; Chima RS; Teusink-Cross A; Hirsch R; Ryan TD; Benoit S; Davies SM
Transplant Cell Ther; 2022 Jul; 28(7):392.e1-392.e9. PubMed ID: 35490975
[TBL] [Abstract][Full Text] [Related]
12. Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand.
Lazana I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674666
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Nrf2 Attenuates Oxidative Stress-Induced, Complement Activation-Associated Endothelial Injury and Apoptosis in Transplant-Associated Thrombotic Microangiopathy.
Zhang R; Qi J; Zhou M; Pan T; Zhang Z; Yao Y; Han H; Han Y
Transplant Cell Ther; 2021 Sep; 27(9):758.e1-758.e8. PubMed ID: 34174470
[TBL] [Abstract][Full Text] [Related]
14. Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic Microangiopathy.
Pan T; Qi J; You T; Han S; Yang L; Miao W; Wu D; Ruan C; Zhu L; Han Y
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1486-1491. PubMed ID: 30871975
[TBL] [Abstract][Full Text] [Related]
15. [The genetic basis of post-bone marrow transplant thrombotic microangiopathy: is this the last piece of the puzzle?].
Mancianti N; Guarnieri A; Tripodi S; Salvo DP; Rollo F; Lenoci M; Toraldo F; Bucalossi A; Garosi G
G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191626
[TBL] [Abstract][Full Text] [Related]
16. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies.
Farkas P; Csuka D; Mikes B; Sinkovits G; Réti M; Németh E; Rácz K; Madách K; Gergely M; Demeter J; Prohászka Z
Immunobiology; 2017 Feb; 222(2):119-127. PubMed ID: 27771173
[TBL] [Abstract][Full Text] [Related]
17. von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy.
Xu Z; Luo C; Lai P; Ling W; Wu S; Huang X; Huang L; Zhang G; Du X; Weng J
Clin Appl Thromb Hemost; 2020; 26():1076029619892684. PubMed ID: 32088973
[TBL] [Abstract][Full Text] [Related]
18. MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy: in vitro and ex vivo evidence.
Elhadad S; Redmond D; Huang J; Tan A; Laurence J
Clin Exp Immunol; 2023 Jul; 213(2):252-264. PubMed ID: 37191586
[TBL] [Abstract][Full Text] [Related]
19. Complement in Pathophysiology and Treatment of Transplant-Associated Thrombotic Microangiopathies.
Jodele S
Semin Hematol; 2018 Jul; 55(3):159-166. PubMed ID: 30032753
[TBL] [Abstract][Full Text] [Related]
20. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
